As we enhance our operational prowess this upcoming weekend and update the necessary systems to better serve you. We will be suspending shipment on Thursday 03/23/2017 - Friday 03/24/2017 and will resume 03/27/2017.
Orders placed after 3pm EST Wednesday March 22nd will ship on Monday March 27th.
LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with acute and chronic illness, cancer, and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands.